•  
  •  
  •  
  •  

2025-10-18 04:37:49

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Choice International Ltd to invest in Fintoo Wealth Pvt Ltd, acquires Distribution Business
  • Brigade Foundation Launches a Landmark Tree Planting Drive of Over 100,000 Trees in Bengaluru's KIADB Area
  • Rail Vikas Nigam Ltd emerges L1 in reverse auction from South Central Railway
  • Yaari Digital Integrated Services Limited is now Indiabulls Ltd
  • MPS Interactive Systems Limited acquires additional stake in Liberate Group

Keywords Selected:  Phase2

Stock Report

  • Powering Growth: Rushil Décor Commences Trial RunProduction at Phase 2 of its State-of-the-Art JumboLaminate Plant
  • XTGlobal announces Phase II Enhancement and Modernization Project Award from U.S. Integrated Healthcare Organization
  • Interarch commissions New Box Column Line in Uttarakhand and commissions Phase 2 of its Andhra Pradesh Unit for Pre-Engineered Steel Buildings
  • Sai Life Sciences completes Phase II of Production Block 11 at Bidar, India, expands capacity to 700 KL
  • Suven Life Sciences announces First Patient Randomized in Phase-2b Clinical Trial of Ropanicant
  • Heranba Organics Pvt Ltd commences Commercial Production at its Sarigam Unit, Phase-II
  • Tata Steel inaugurates Phase II expansion of Kalinganagar operations
  • Max Estates achieves pre-sales booking value of INR 845 Crores within a week of the launch of Phase II of Estate 128 project in Noida
  • Interarch to Expand Installed Capacity with Phase 2 Andhra Pradesh Unit and Kichha Plant Upgrade, Strengthens R&D Initiatives
  • NTPC Ltd board approves investment for Telangana Super Thermal Power Project, Phase 2
  • Zydus and ICMR initiate a Phase 2 proof-of-concept trial of Desidustat in patients with Sickle Cell Disease
  • Suven Life Sciences to Present Positive Results from Phase-2a Proof-of-Concept Study of Ropanicant
  • Birla Estates sets a remarkable precedent in Bengaluru with a booking value of about Rs. 600 crore for Birla Trimaya Phase 2
  • Tata Steel commissions India's largest blast furnace at Kalinganagar
  • Suven Life Sciences Announces Positive Topline Results from Phase-2a Proof-of-Concept Signal Detection Open Label Study of Ropanicant
  • Max House - Phase 2 Achieves 100% Occupancy in less than a year of its completion
  • Zydus Lifesciences announces completion of Phase II(a) clinical trial of Usnoflast
  • Sun Pharma and Moebius Medical Ltd present Phase 2b study on MM-II
  • Suven Life Sciences to present Phase-2 Positive Results on Samelisant at American Academy of Neurology2024 Annual Meeting, Denver, USA
  • Lumax Industries Limited approves expansion projects
  • Zydus receives approval from USFDA to initiate Phase II clinical trial of ZYIL1 in patients with Parkinson's disease
  • Max Estates receives Completion Cum Occupancy Certificate for Phase 2 of Max House, a boutique office campus, in Okhla, South Delhi
  • Ultramarine Specialty Chemicals Ltd commissions pigments project phase-2
  • Titagarh Rail Systems Ltd receives LOA from GMRC worth Rs. 350 crore

Latest Post

  • Choice International Ltd to invest in Fintoo Wealth Pvt Ltd, acquires Distribution Business
  • Brigade Foundation Launches a Landmark Tree Planting Drive of Over 100,000 Trees in Bengaluru's KIADB Area
  • Rail Vikas Nigam Ltd emerges L1 in reverse auction from South Central Railway
  • Yaari Digital Integrated Services Limited is now Indiabulls Ltd
  • MPS Interactive Systems Limited acquires additional stake in Liberate Group


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024